Stories tagged with this clinical concept across ZayedMD's coverage.
4 stories · Updated May 12, 2026
Reading Time: 5 minutesThe recent FDA approval of Foundayo (orforglipron) marks a significant milestone in chronic weight management. For the first time, patients and clinicians have access to a small-molecule, non-peptide GLP-1 receptor agonist in…
Reading Time: 2 minutesIf you are trying to start Foundayo (orforglipron), the biggest blocker is usually not eligibility, it is access and out-of-pocket cost. This guide gives you a practical, physician-reviewed checklist to reduce delays…
Reading Time: 4 minutesNovo Nordisk, the manufacturer of the popular GLP-1 medication Wegovy (semaglutide), has introduced a new multi-month subscription program designed to make this FDA-approved obesity treatment more accessible and affordable for self-pay patients…
Reading Time: 4 minutesFull body MRI is becoming a popular preventive screening option. Here is what a full body MRI scan may show, what it may cost, and when it may be worth considering.